1570EGP
- Active ingredient
- anagrelide
- Strength
- 0.5mg
- Form
- capsule
- Manufacturer
- marcyrl co.
- Route
- oral.solid
Uses
Treatment of thrombocythemia associated with myeloproliferative neoplasms to reduce elevated platelet counts.
Do not use if
No absolute contraindications established; hypersensitivity should be avoided.
Side effects
Headache, palpitations, diarrhea, edema.
Warnings
May cause cardiovascular toxicity, QT prolongation and pulmonary hypertension.
How it works
Reduces platelet production by affecting megakaryocyte maturation.
Storage
Store at 25°C with permitted room-temperature excursions.